PURPOSE: The presence of single nucleotide polymorphisms (SNPs) has been reported for multidrug resistance-associated protein 2 (MRP2/ABCC2). The purpose of the current study was to characterize the localization, expression level, and function of MRP2 variants. METHODS: The expression and cellular localization of the wild-type and three kinds of reported SNP variants of MRP2 molecules were analyzed in LLC-PK1 cells after infection with the recombinant Tet-off adenoviruses. Their function was determined by using the isolated membrane vesicles from the infected LLC-PK1 cells. RESULTS: The transport activity for E217betaG, LTC4, and DNP-SG, normalized by the expression level of MRP2, was similar between the wild-type, V417I, and A1450T MRP2s. The transport activity of S789F MRP2 was slightly higher than that of wild-type MRP2. However, the expression level of S789F and A1450T MRP2 proteins was significantly lower compared with the wild-type and V417I MRP2. In addition, although the wild-type and V417I MRP2 were exclusively localized in the apical membrane, S789F and A1450T MRP2 were located in the apical membrane and also in the intracellular compartment. CONCLUSIONS: These results suggest that the most frequently observed V417I substitution may not affect the in vivo function of MRP2, whereas the much less frequently observed S789F and A1450T may be associated with the reduced in vivo function.
PURPOSE: The presence of single nucleotide polymorphisms (SNPs) has been reported for multidrug resistance-associated protein 2 (MRP2/ABCC2). The purpose of the current study was to characterize the localization, expression level, and function of MRP2 variants. METHODS: The expression and cellular localization of the wild-type and three kinds of reported SNP variants of MRP2 molecules were analyzed in LLC-PK1 cells after infection with the recombinant Tet-off adenoviruses. Their function was determined by using the isolated membrane vesicles from the infected LLC-PK1 cells. RESULTS: The transport activity for E217betaG, LTC4, and DNP-SG, normalized by the expression level of MRP2, was similar between the wild-type, V417I, and A1450T MRP2s. The transport activity of S789FMRP2 was slightly higher than that of wild-type MRP2. However, the expression level of S789F and A1450TMRP2 proteins was significantly lower compared with the wild-type and V417IMRP2. In addition, although the wild-type and V417IMRP2 were exclusively localized in the apical membrane, S789F and A1450TMRP2 were located in the apical membrane and also in the intracellular compartment. CONCLUSIONS: These results suggest that the most frequently observed V417I substitution may not affect the in vivo function of MRP2, whereas the much less frequently observed S789F and A1450T may be associated with the reduced in vivo function.
Authors: M Wada; S Toh; K Taniguchi; T Nakamura; T Uchiumi; K Kohno; I Yoshida; A Kimura; S Sakisaka; Y Adachi; M Kuwano Journal: Hum Mol Genet Date: 1998-02 Impact factor: 6.150
Authors: Tristan M Sissung; Sarah M Troutman; Tessa J Campbell; Heather M Pressler; Hyeyoung Sung; Susan E Bates; William D Figg Journal: Discov Med Date: 2012-01 Impact factor: 2.970
Authors: N Božina; Z Lalić; S Nađ-Škegro; A Borić-Bilušić; T Božina; Ž Kaštelan; V Trkulja Journal: Eur J Clin Pharmacol Date: 2017-06-18 Impact factor: 2.953
Authors: Victoria M Pratt; Brittany N Beyer; Daniel L Koller; Todd C Skaar; David A Flockhart; Kenneth D Levy; Gail H Vance Journal: J Mol Diagn Date: 2014-12-29 Impact factor: 5.568
Authors: Vandana Megaraj; Tianyong Zhao; Christian M Paumi; Phillip M Gerk; Richard B Kim; Mary Vore Journal: Pharmacogenet Genomics Date: 2011-08 Impact factor: 2.089
Authors: S M Markova; T De Marco; N Bendjilali; E A Kobashigawa; J Mefford; J Sodhi; H Le; C Zhang; J Halladay; A E Rettie; C Khojasteh; D McGlothlin; A H B Wu; W-C Hsueh; J S Witte; J B Schwartz; D L Kroetz Journal: Clin Pharmacol Ther Date: 2013-07-17 Impact factor: 6.875
Authors: Nada Abla; Leslie W Chinn; Tsutomu Nakamura; Li Liu; Conrad C Huang; Susan J Johns; Michiko Kawamoto; Doug Stryke; Travis R Taylor; Thomas E Ferrin; Kathleen M Giacomini; Deanna L Kroetz Journal: J Pharmacol Exp Ther Date: 2008-03-25 Impact factor: 4.030
Authors: Richard H Ho; Leena Choi; Wooin Lee; Gail Mayo; Ute I Schwarz; Rommel G Tirona; David G Bailey; C Michael Stein; Richard B Kim Journal: Pharmacogenet Genomics Date: 2007-08 Impact factor: 2.089